Similar articles for PMID: 26497529

Year	Number of Results
1995	1
1998	2
2001	1
2002	2
2003	2
2004	1
2005	1
2006	2
2007	3
2010	1
2011	3
2012	1
2013	5
2014	3
2015	12
2016	6
2017	3
2018	1
2019	4
2020	4
2021	2
2022	0

1

The role of Fc receptors in HIV prevention and therapy.

Boesch AW, Brown EP, Ackerman ME. Boesch AW, et al. Immunol Rev. 2015 Nov;268(1):296-310. doi: 10.1111/imr.12339. Immunol Rev. 2015. PMID: 26497529 Free PMC article. Review.

2

Fc receptor-mediated phagocytosis in tissues as a potent mechanism for preventive and therapeutic HIV vaccine strategies.

Sips M, Krykbaeva M, Diefenbach TJ, Ghebremichael M, Bowman BA, Dugast AS, Boesch AW, Streeck H, Kwon DS, Ackerman ME, Suscovich TJ, Brouckaert P, Schacker TW, Alter G. Sips M, et al. Mucosal Immunol. 2016 Nov;9(6):1584-1595. doi: 10.1038/mi.2016.12. Epub 2016 Feb 17. Mucosal Immunol. 2016. PMID: 26883728 Free PMC article.

3

Antibody Functional Assays as Measures of Fc Receptor-Mediated Immunity to HIV - New Technologies and their Impact on the HIV Vaccine Field.

Wines BD, Billings H, Mclean MR, Kent SJ, Hogarth PM. Wines BD, et al. Curr HIV Res. 2017;15(3):202-215. doi: 10.2174/1570162X15666170320112247. Curr HIV Res. 2017. PMID: 28322167 Free PMC article. Review.

4

HIV/AIDS: allied responses.

Mascola JR. Mascola JR. Nature. 2007 Sep 6;449(7158):29-30. doi: 10.1038/449029a. Nature. 2007. PMID: 17805280 No abstract available.

5

Fc receptor but not complement binding is important in antibody protection against HIV.

Hessell AJ, Hangartner L, Hunter M, Havenith CE, Beurskens FJ, Bakker JM, Lanigan CM, Landucci G, Forthal DN, Parren PW, Marx PA, Burton DR. Hessell AJ, et al. Nature. 2007 Sep 6;449(7158):101-4. doi: 10.1038/nature06106. Nature. 2007. PMID: 17805298

6

Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles.

Brown EP, Dowell KG, Boesch AW, Normandin E, Mahan AE, Chu T, Barouch DH, Bailey-Kellogg C, Alter G, Ackerman ME. Brown EP, et al. J Immunol Methods. 2017 Apr;443:33-44. doi: 10.1016/j.jim.2017.01.010. Epub 2017 Feb 3. J Immunol Methods. 2017. PMID: 28163018 Free PMC article.

7

Antibody-Based Preventive and Therapeutic Strategies Against HIV.

Fabra-Garcia A, Beltran C, Sanchez-Merino V, Yuste E. Fabra-Garcia A, et al. Curr HIV Res. 2016;14(3):260-9. doi: 10.2174/1570162x14999160224103320. Curr HIV Res. 2016. PMID: 26957200 Review.

8

Qualitative and quantitative variables that affect the potency of Fc- mediated effector function in vitro and in vivo: considerations for passive immunization using non-neutralizing antibodies.

Lewis GK. Lewis GK. Curr HIV Res. 2013 Jul;11(5):354-64. doi: 10.2174/1570162x113116660060. Curr HIV Res. 2013. PMID: 24191940 Review.

9

Expression Profile of Human Fc Receptors in Mucosal Tissue: Implications for Antibody-Dependent Cellular Effector Functions Targeting HIV-1 Transmission.

Cheeseman HM, Carias AM, Evans AB, Olejniczak NJ, Ziprin P, King DF, Hope TJ, Shattock RJ. Cheeseman HM, et al. PLoS One. 2016 May 10;11(5):e0154656. doi: 10.1371/journal.pone.0154656. eCollection 2016. PLoS One. 2016. PMID: 27164006 Free PMC article.

10

Quantifying the contribution of Fc-mediated effector functions to the antiviral activity of anti-HIV-1 IgG1 antibodies in vivo.

Wang P, Gajjar MR, Yu J, Padte NN, Gettie A, Blanchard JL, Russell-Lodrigue K, Liao LE, Perelson AS, Huang Y, Ho DD. Wang P, et al. Proc Natl Acad Sci U S A. 2020 Jul 28;117(30):18002-18009. doi: 10.1073/pnas.2008190117. Epub 2020 Jul 14. Proc Natl Acad Sci U S A. 2020. PMID: 32665438 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed